Slides | Lp(a) contribution to PCSK9-ab benefit in ODYSSEY
Slides as educational service to PACE members and meeting participants
This lecture by Wouter Jukema was part of the EAS endorsed satellite meeting "The imminent danger of Lp(a): Time to face the challenge" held prior to the 87th EAS congress in Maastricht, The Netherlands.
The presentation was prepared and held by Wouter Jukema, Professor of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
This satellite symposium was supported by an unrestricted educational grant from Amgen and Novartis.
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: